XOMA Royalty (XOMA) Other Working Capital Changes (2010 - 2026)
XOMA Royalty (XOMA) reported Other Working Capital Changes of -$656000.0 for Q1 2026, down 507.41% on a YoY basis from $161018.2 in Q1 2025, and down 7.89% sequentially from -$608000.0 in Q4 2025.
XOMA Royalty (XOMA) Other Working Capital Changes (2010 - 2026) Analysis & Trends
XOMA Royalty (XOMA) has 7 years of Other Working Capital Changes data on file, last reported at -$656000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes fell 507.41% year-over-year to -$656000.0; the trailing twelve-month figure through Mar 2026 stood at -$1.5 million (down 293.37% YoY), and the FY2025 full-year result was -$876000.0, down 208.45% from the prior year.
- Other Working Capital Changes eased to -$656000.0 in Q1 2026, from -$608000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $1.3 million in Q4 2022 to a low of -$3.6 million in Q4 2024.
- A 5-year average of -$525437.5 and a median of -$431500.0 in 2022 frame the typical range for Other Working Capital Changes.
- Across the five-year window, Other Working Capital Changes soared 111.76% in 2023 and plunged 1750.0% in 2024, its largest moves.
- Tracing XOMA's Other Working Capital Changes over 5 years: stood at -$51000.0 in 2022, then soared by 111.76% to $6000.0 in 2023, then sank by 1750.0% to -$99000.0 in 2024, then plunged by 514.14% to -$608000.0 in 2025, then fell by 7.89% to -$656000.0 in 2026.
- Business Quant data shows XOMA's Other Working Capital Changes at -$656000.0 in Q1 2026, -$608000.0 in Q4 2025, and -$111000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | XOMA Royalty | 478.42 Mn | 412.34 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -753,000.00 |
| Mar 31, 2026 | -753,000.00 |
| Mar 31, 2026 | -753,000.00 |
| Dec 31, 2025 | -332,000.00 |
| Dec 31, 2025 | -332,000.00 |
| Dec 31, 2025 | -332,000.00 |
| Jun 30, 2025 | -1.40 Mn |
| Jun 30, 2025 | -1.40 Mn |
| Jun 30, 2025 | -1.40 Mn |
| Mar 31, 2025 | -317,000.00 |
| Mar 31, 2025 | -317,000.00 |
| Mar 31, 2025 | -317,000.00 |
| Dec 31, 2024 | -3.64 Mn |
| Dec 31, 2024 | -3.64 Mn |
| Dec 31, 2024 | -3.64 Mn |
| Sep 30, 2024 | 1.19 Mn |
| Sep 30, 2024 | 1.19 Mn |
| Sep 30, 2024 | 1.19 Mn |
| Jun 30, 2024 | -904,000.00 |
| Jun 30, 2024 | -904,000.00 |